Engineers Gate Manager’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Buy |
+88,827
| New | +$110K | ﹤0.01% | 1982 |
|
|
2024
Q3 | – | Sell |
-102,260
| Closed | -$140K | – | 2322 |
|
|
2024
Q2 | $140K | Sell |
102,260
-195,611
| -66% | -$268K | ﹤0.01% | 1701 |
|
|
2024
Q1 | $1.12M | Buy |
297,871
+277,071
| +1,332% | +$1.04M | 0.03% | 762 |
|
|
2023
Q4 | $204K | Buy |
+20,800
| New | +$204K | 0.01% | 1634 |
|
|
2022
Q2 | – | Sell |
-402,217
| Closed | -$3.66M | – | 2161 |
|
|
2022
Q1 | $3.66M | Buy |
402,217
+389,169
| +2,983% | +$3.54M | 0.14% | 155 |
|
|
2021
Q4 | $267K | Sell |
13,048
-11,619
| -47% | -$238K | 0.01% | 1478 |
|
|
2021
Q3 | $630K | Sell |
24,667
-21,711
| -47% | -$555K | 0.04% | 744 |
|
|
2021
Q2 | $1.62M | Buy |
+46,378
| New | +$1.62M | 0.1% | 237 |
|
|
2021
Q1 | – | Sell |
-13,370
| Closed | -$347K | – | 2049 |
|
|
2020
Q4 | $347K | Sell |
13,370
-18,251
| -58% | -$474K | 0.02% | 1202 |
|
|
2020
Q3 | $312K | Sell |
31,621
-9,538
| -23% | -$94.1K | 0.01% | 1229 |
|
|
2020
Q2 | $142K | Buy |
41,159
+8,703
| +27% | +$30K | 0.01% | 1518 |
|
|
2020
Q1 | $99K | Sell |
32,456
-149,407
| -82% | -$456K | 0.01% | 1416 |
|
|
2019
Q4 | $935K | Sell |
181,863
-8,296
| -4% | -$42.7K | 0.04% | 678 |
|
|
2019
Q3 | $981K | Buy |
+190,159
| New | +$981K | 0.05% | 546 |
|
|
2018
Q4 | – | Sell |
-165,321
| Closed | -$894K | – | 1064 |
|
|
2018
Q3 | $894K | Buy |
+165,321
| New | +$894K | 0.07% | 372 |
|